Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, October 2012

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 16 news outlets
policy: 1 policy source

twitter: 6 X users
patent: 8 patents

Readers on

mendeley: 263 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 8 patents that reference this research output.

Spray dried formulation of a cholera toxin B subunit variant

Grant US-12343375-B2

United States of America

01 Jul 2025

Cyclic HIV-1 Env V3 glycopeptide immunogens

Grant US-10286057-B2

United States of America

14 May 2019

Methods for producing antibodies

Grant US-10066238-B2

United States of America

04 Sep 2018

ENGINEERED OUTER DOMAIN (EOD) OF HIV GP120, MUTANTS AND USE THEREOF

Application WO-2016205704-A2

World Intellectual Property Organisation (WIPO)

22 Dec 2016

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.